Corrigendum to “Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels” [Journal of Substance Abuse Treatment 47 (2014) 245–250](S0740547214000907)(10.1016/j.jsat.2014.06.001);Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels

Journal of Substance Abuse Treatment

Volumn 47, Issue 4, 2014, Pages 245-250

  D'Aunno, Thomas ^a   Pollack, Harold A ^b   Frimpong, Jemima A ^c   Wuchiett, David ^c  

^a Columbia University ^*  (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c Department of Medicine   (United States)

Author keywords

Dose levels; Methadone; Opioid disorders; Organizational correlates

Indexed keywords

METHADONE;

ACCREDITATION; ADULT; AFRICAN AMERICAN; ARTICLE; ATTITUDE; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; HEALTH PROGRAM; HEALTH SURVEY; HISPANIC; HUMAN; MAJOR CLINICAL STUDY; METHADONE TREATMENT; OPIATE ADDICTION; PRIORITY JOURNAL; TIME; UNEMPLOYMENT; CLINICAL PRACTICE; DOSE RESPONSE; EVIDENCE BASED MEDICINE; HEALTH CARE DELIVERY; HEROIN DEPENDENCE; LONGITUDINAL STUDY; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

DOSE-RESPONSE RELATIONSHIP, DRUG; EVIDENCE-BASED MEDICINE; HEALTH SERVICES ACCESSIBILITY; HEROIN DEPENDENCE; HUMANS; LONGITUDINAL STUDIES; METHADONE; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 84906101723     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2017.05.001     Document Type: Erratum

References (33)

1. Adams T.K. Outpatient Substance Abuse Treatment Surveys (OSATSS) sampling and weighting documentation for OSATSS-6, 2004. Survey Research Center, Institute for Social Research 2005, University of Michigan, Ann Harbor.
2. Adams T.A., Heeringa S.G. Outpatient Substance Abuse Treatment System Surveys (OSATSS): Technical documentation for OSATSS-5, 1999-2000 2001, Institute for Social Research, Survey Design and Analysis Unit, University of Michigan, Ann Arbor.
3. Amato L., Davoli M., Perucci C.A., Ferri M., Faggiano F., Mattick R.P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: Available evidence to inform clinical practice and research. Journal of Substance Abuse Treatment 2005, 28(4):321-329. 10.1016/j.jsat.2005.02.007.
4. Batten H.L., Prottas J.M., Horgan C.M. Drug services research survey, final report: Phase II 1992, Institute for Health Policy, Brandeis University, National Institute on Drug Abuse, Waltham, MA.
5. Caplehorn J.R., Lumley T.S., Irwig L. Staff attitudes and retention of patients in methadone maintenance programs. Drug and Alcohol Dependence 1998, 52(9788007):57-61.
6. CDC HIV infection and HIV-associated behaviors among injecting drug users - 20 Cities, United States. Morbidity and Mortality Weekly 2009, 61(08):133-138. (Retrieved March, 2, 2012, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6108a1.htm).
7. CDC Vital signs: Overdoses of prescription opioid pain relievers-United States, 1999-2008. Morbidity and Mortality Weekly Report 2013, July 5, 62(26):537-542. (Retrieved June 3, 2013, from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6043a4.htm).
8. D'Aunno T., Pollack H.A. Changes in methadone treatment practices: Results from a national panel study, 1988-2000. JAMA 2002, 288(7):850-856. (doi: joc11894 [pii]).
9. D'Aunno T., Vaughn T.E. Variations in methadone treatment practices. JAMA, the Journal of the American Medical Association 1992, 267(2):253-258.
10. Des Jarlais D.C., Semaan S. HIV prevention for injecting drug users: The first 25years and counting. Psychosomatic Medicine 2008, 70(5):606-611. 10.1097/PSY.0b013e3181772157.
11. Diggle P.J., Liang K.Y., Zeger S.L. Analysis of longitudinal data 1994, Oxford University Press, Oxford, UK.
12. Faggiano F., Vigna-Taglianti F., Versino E., Lemma P. Methadone maintenance at different dosages for opioid dependence. The Cochrane Library 2003, (Issue 3 Update Software, Oxford).
13. Groves R.M. Telephone survey methodology 1988, Wiley and Sons, New York.
14. Hsiao Cheng Analysis of panel data 2003, Cambridge University Press, Cambridge, UK. 2nd ed.
15. Institute of Medicine Federal regulation of methadone 1994.
16. Johnson R.E., Chutuape M.A., Strain E.C., Walsh S.L., Stitzer M.L., Bigelow G.E. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. New England Journal of Medicine 2000, 343(18):1290-1297. 10.1056/nejm200011023431802.
17. Kleber H.D. The National Evaluation of Substance Abuse Treatment study. Paper presented at the College on Studies of Drug Dependence, 62nd Annual Meeting, San Juan, Puerto Rico 2000.
18. Kleber H.D. Methadone maintenance 4 decades later: Thousands of lives saved but still controversial. JAMA 2008, 300(19):2303-2305. 10.1001/jama.2008.648.
19. Lemak C.H., Alexander J.A. Managed care and outpatient substance abuse treatment intensity. Journal of Behavioral Health Services and Research 2001, 28(11329996):12-29.
20. Little R., Rubin D. Statistical analysis with missing data 2002, Wiley-Interscience, New York.
21. Mattick R.P., Breen C., Kimber J., Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database of Systematic Reviews 2009, (3). 10.1002/14651858.CD002209.pub2.
22. Mattick R.P., Kimber J., Breen C., Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database of Systematic Reviews 2008, (2). 10.1002/14651858.CD002207.pub3.
23. National Institute of Health Consensus statement 108: Effective medical treatment of opiate addiction Retrieved August 23, 2013, from. http://consensus.nih.gov/1997/1998TreatOpiateAddiction108html.htm.
24. Newman Robert G., Whitehill Walden B. Double-blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. The Lancet 1979, 314(8141):485-488. 10.1016/S0140-6736(79)91550-2.
25. Nosyk B., Anglin M.D., Brissette S., Kerr T., Marsh D.C., Schackman B.R., et al. A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Affairs (Millwood) 2013, 32(8):1462-1469. 10.1377/hlthaff.2012.0846.
26. Pollack H.A., D'Aunno T. Dosage patterns in methadone treatment: Results from a national survey, 1988-2005. Health Services Research 2008, 43(6):2143-2163. (HESR870 [pii]). 10.1111/j.1475-6773.2008.00870.x.
27. Rettig R.A., Yarmolinsky A. Federal regulation of methadone treatment 1995, National Academy Press, Washington, DC.
28. SAMHSA Results from the 2011 National Survey on Drug Use and Health: Summary of national findings, NSDUH Series H-44, HHS Publication No. (SMA) 12-4713 2012, (Rockville, MD).
29. Simpson D.Dwayne, Joe George W., Brown Barry S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behaviors 1997, 11(4):294-307. 10.1037/0893-164X.11.4.294.
30. StataCorp Stata Statistical Software: Release 12 2011, StataCorp LP, College Station, TX.
31. Strain E.C. Methadone dose during maintenance treatment in the treatment of opioid dependence 2006, Johns Hopkins Press, Baltimore, MD.
32. Strain E.C., Bigelow G.E., Liebson I.A., Stitzer M.L. Moderate- vs high-dose methadone in the treatment of opioid dependence: A randomized trial. JAMA 1999, 281(10086434):1000-1005.
33. Substance Abuse and Mental Health Services Administration Office of Applied Studies National Survey of Substance Abuse Treatment Services (N-SSATS) 2009, (Retrieved September 22, 2009, from www.oas.samhsa.gov/nssats2k7/nssats2k7toc.cfm).